PL1858915T3 - Warianty wirusa zapalenia wątroby typu B oporne na pewne analogi nukleozydów ale wrażliwe na inne i ich zastosowania - Google Patents
Warianty wirusa zapalenia wątroby typu B oporne na pewne analogi nukleozydów ale wrażliwe na inne i ich zastosowaniaInfo
- Publication number
- PL1858915T3 PL1858915T3 PL06723428T PL06723428T PL1858915T3 PL 1858915 T3 PL1858915 T3 PL 1858915T3 PL 06723428 T PL06723428 T PL 06723428T PL 06723428 T PL06723428 T PL 06723428T PL 1858915 T3 PL1858915 T3 PL 1858915T3
- Authority
- PL
- Poland
- Prior art keywords
- hepatitis
- variants
- sensitive
- nucleoside analogues
- resistant against
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1241—Nucleotidyltransferases (2.7.7)
- C12N9/1276—RNA-directed DNA polymerase (2.7.7.49), i.e. reverse transcriptase or telomerase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/706—Specific hybridization probes for hepatitis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
- G01N33/5761—Hepatitis B
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G01N2333/02—Hepadnaviridae, e.g. hepatitis B virus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Virology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US66148305P | 2005-03-15 | 2005-03-15 | |
EP05102014 | 2005-03-15 | ||
PCT/EP2006/002351 WO2006097284A1 (en) | 2005-03-15 | 2006-03-14 | Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
EP06723428.6A EP1858915B1 (en) | 2005-03-15 | 2006-03-14 | Variants of hepatitis b virus resistant against some nucleoside analogues, but sensitive to others, and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
PL1858915T3 true PL1858915T3 (pl) | 2015-01-30 |
Family
ID=35276399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL06723428T PL1858915T3 (pl) | 2005-03-15 | 2006-03-14 | Warianty wirusa zapalenia wątroby typu B oporne na pewne analogi nukleozydów ale wrażliwe na inne i ich zastosowania |
Country Status (7)
Country | Link |
---|---|
US (1) | US7807437B2 (pl) |
EP (1) | EP1858915B1 (pl) |
AU (1) | AU2006224788B2 (pl) |
ES (1) | ES2470318T3 (pl) |
PL (1) | PL1858915T3 (pl) |
PT (1) | PT1858915E (pl) |
WO (1) | WO2006097284A1 (pl) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPO351996A0 (en) * | 1996-11-08 | 1996-12-05 | Western Health Care Network | Viral variants and methods for detecting same |
USRE40233E1 (en) | 1996-11-08 | 2008-04-08 | Melbourne Health | Viral variants and methods for detecting same |
US7405039B2 (en) * | 2002-02-07 | 2008-07-29 | Austin Health | Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
US8278432B2 (en) * | 2002-03-29 | 2012-10-02 | Innogenetics N.V. | HBV drug resistance methods |
WO2003087351A1 (en) | 2002-04-12 | 2003-10-23 | Melbourne Health | Hepatitis b viral variants with redused susceptibility to nucleoside analogs and uses thereof |
PT1858916E (pt) | 2005-03-15 | 2014-10-06 | Fujirebio Europ N V | Variantes virais da hepatite b com uma susceptibilidade reduzida para análogos de nucleósidos e as suas utilizações |
PL1858915T3 (pl) | 2005-03-15 | 2015-01-30 | Univ Bonn Rheinische Friedrich Wilhelms | Warianty wirusa zapalenia wątroby typu B oporne na pewne analogi nukleozydów ale wrażliwe na inne i ich zastosowania |
AU2006230802A1 (en) * | 2005-04-08 | 2006-10-12 | Austin Health | Variants of hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof |
EP1874923A4 (en) * | 2005-04-08 | 2010-08-04 | Melbourne Health | VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF |
US9682109B2 (en) | 2005-10-21 | 2017-06-20 | Abl Sa | Antiviral resistance mutants and applications thereof |
CN101548014B (zh) | 2006-06-06 | 2012-07-04 | 墨尔本保健公司 | 抗病毒抗性突变的检测和应用 |
DE102007062962A1 (de) | 2007-12-21 | 2009-06-25 | Siemens Healthcare Diagnostics Products Gmbh | Neue Oberflächen-Protein-Mutante des Hepatitis B Virus HBV surface Antigen (HBsAg) |
US9963751B2 (en) | 2015-11-24 | 2018-05-08 | The Penn State Research Foundation | Compositions and methods for identifying agents to reduce hepatitis B virus covalently closed circular DNA |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5595739A (en) | 1993-05-07 | 1997-01-21 | Abbott Laboratories | Hepatitis B virus mutants, reagents and methods for detection |
ZA973367B (en) | 1996-04-19 | 1997-11-18 | Innogenetics Nv | Method for typing and detecting HBV. |
AUPO351996A0 (en) * | 1996-11-08 | 1996-12-05 | Western Health Care Network | Viral variants and methods for detecting same |
JP2000270876A (ja) | 1999-03-26 | 2000-10-03 | Genome Science Laboratories Co Ltd | B型肝炎ウイルス遺伝子の変異検出方法および検出キット |
AUPP967999A0 (en) | 1999-04-09 | 1999-05-06 | North Western Health Care Network | Viral variants |
CN100497604C (zh) | 2002-02-07 | 2009-06-10 | 墨尔本保健公司 | 对核苷类似物具有改变的敏感性的病毒变体及其应用 |
US8278432B2 (en) * | 2002-03-29 | 2012-10-02 | Innogenetics N.V. | HBV drug resistance methods |
WO2003087351A1 (en) * | 2002-04-12 | 2003-10-23 | Melbourne Health | Hepatitis b viral variants with redused susceptibility to nucleoside analogs and uses thereof |
US20040194155A1 (en) * | 2002-10-01 | 2004-09-30 | Gilead Sciences, Inc. | HBV mutations associated with reduced susceptibility to adefovir |
PT1858916E (pt) * | 2005-03-15 | 2014-10-06 | Fujirebio Europ N V | Variantes virais da hepatite b com uma susceptibilidade reduzida para análogos de nucleósidos e as suas utilizações |
PL1858915T3 (pl) | 2005-03-15 | 2015-01-30 | Univ Bonn Rheinische Friedrich Wilhelms | Warianty wirusa zapalenia wątroby typu B oporne na pewne analogi nukleozydów ale wrażliwe na inne i ich zastosowania |
-
2006
- 2006-03-14 PL PL06723428T patent/PL1858915T3/pl unknown
- 2006-03-14 AU AU2006224788A patent/AU2006224788B2/en not_active Ceased
- 2006-03-14 EP EP06723428.6A patent/EP1858915B1/en active Active
- 2006-03-14 WO PCT/EP2006/002351 patent/WO2006097284A1/en not_active Application Discontinuation
- 2006-03-14 ES ES06723428.6T patent/ES2470318T3/es active Active
- 2006-03-14 PT PT67234286T patent/PT1858915E/pt unknown
- 2006-03-15 US US11/375,580 patent/US7807437B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
US7807437B2 (en) | 2010-10-05 |
ES2470318T3 (es) | 2014-06-23 |
AU2006224788A1 (en) | 2006-09-21 |
WO2006097284A1 (en) | 2006-09-21 |
EP1858915A1 (en) | 2007-11-28 |
PT1858915E (pt) | 2014-06-11 |
AU2006224788B2 (en) | 2012-08-16 |
US20070042356A1 (en) | 2007-02-22 |
EP1858915B1 (en) | 2014-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL1858915T3 (pl) | Warianty wirusa zapalenia wątroby typu B oporne na pewne analogi nukleozydów ale wrażliwe na inne i ich zastosowania | |
IL200432A (en) | Human antibodies against hepatitis C virus and their uses | |
GB0718984D0 (en) | Structure of the hepatitis C virus NS5A protein | |
IL240244A0 (en) | Macrocyclic inhibitors of hepatitis c virus | |
PL1858916T4 (pl) | Warianty wirusa zapalenia wątroby typu b z obniżoną wrażliwością na analogi nukleozydów i ich zastosowanie | |
AP2585A (en) | Macrocyclic inhibitors of hepatitis C virus | |
AP2473A (en) | Macrocyclic inhibitors of hepatitis C virus | |
HK1126486A1 (en) | Hepatitis c virus inhibitors (hcv) | |
IL176486A0 (en) | Azabenzofuran substituted thioureas as inhibtitors of viral replication | |
PL1912997T3 (pl) | Makrocykliczne inhibitory wirusa zapalenia wątroby typu C | |
PL1919904T3 (pl) | Makrocykliczne inhibitory wirusa zapalenia wątroby typu C | |
PL1919898T3 (pl) | Makrocykliczne inhibitory wirusa zapalenia wątroby typu C | |
PL1913015T3 (pl) | Makrocykliczne inhibitory wirusa zapalenia wątroby typu C | |
IL188281A0 (en) | Macrocyclic inhibitors of hepatitis c virus | |
ZA200705145B (en) | Rescue of influenza virus | |
EP2346329A4 (en) | METHOD OF INHIBITING HEPATITIS C VIRUS BY COMBINING A 5,6-DIHYDRO-1H-PYRIDIN-2-ON AND ONE OR MULTIPLE ANTIVIRAL COMPOUNDS | |
IL194920A0 (en) | Hepatitis c virus infection biomarkers | |
EP2177535A4 (en) | ANTIBODIES HAVING INHIBITORY ACTIVITY ON HEPATITIS C VIRUS INFECTION (HCV) AND USE THEREOF | |
EP1499712A4 (en) | HEPATITIS B VIRUS VARIANTS WITH REDUCED SENSITIVITY TO NUCLEOSIDANALOGES AND USE THEREOF | |
EP1874923A4 (en) | VARIANTS OF THE HEPATITIS B VIRUS WITH RESISTANCE TO ANTIVIRAL NUCLEOSIDAGENTS AND APPLICATIONS THEREOF | |
EP1982728A4 (en) | HEPATITIS C-VIRUS DERIVED PEPTIDE | |
ZA200708522B (en) | Variants of Hepatitis B virus with resistance to anti-viral nucleoside agents and applications thereof | |
CL2007001003A1 (es) | Compuestos derivados de amidas; y uso en el tratamiento de un trastorno asociado con el virus de hepatitis c. | |
DK1945797T3 (da) | Hepatitis C-virus NS2/3-aktivitetsanalyse | |
ZA200800859B (en) | Macrocyclic inhibitors of hepatitis C virus |